Allogeneic regulatory T-cell immunotherapy with HSPC and T cells (Tregzi)
Customize your policy alerts
Sign up for UPMC Health Plan Policy RX.PA.1025 alerts
Get alerted when Policy RX.PA.1025 changes without checking for updates manually.
Monitor payer policy activity
This policy appears to address Medicaid coverage of Tregzi, an allogeneic regulatory T-cell immunotherapy involving hematopoietic stem and progenitor cells (HSPC) and T cells.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.